The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction : α-Blockers in the Treatment of Male Voiding Dysfunction-How Do They Work and Why Do They Differ in Tolerability?

スポンサーリンク

概要

• 論文の詳細を見る
• 2010-02-20

著者

• Michel Martin

  Department Of Pharmacology & Pharmacotherapy Academic Medical Center University Of Amsterdam

関連論文

• Nocturia : A non-specific but important symptom of urological disease
• A rapid and validated HPLC method to quantify sphingosine 1-phosphate in human plasma using solid-phase extraction followed by derivatization with fluorescence detection
• The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction : α-Blockers in the Treatment of Male Voiding Dysfunction-How Do They Work and Why Do They Differ in Tolerability?

スポンサーリンク